Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767936 · ClinicalTrials.gov registry record
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 135
- Enrollment target
NCT00767936: Clinical Trial study, sponsored by Stanford University.
NCT00767936 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 135 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767936 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 135 participants
- Enrollment target
Study Summary
Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00767936
The ClinicalTrials.gov registry entry for NCT00767936 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00767936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00767936 about?
NCT00767936 is a clinical study titled "Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma". Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chron...
What is the current status of trial NCT00767936?
This trial is currently terminated. The enrollment target is 135 participants. The study started on 2008-03. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT00767936?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.